Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
VVOS Quote, Financials, Valuation and Earnings
Last price:
$2.04
Seasonality move
:
-23.32%
Day range:
$2.00 - $2.07
52-week range:
$1.93 - $7.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.03x
P/B ratio:
7.31x
Volume:
43.4K
Avg. volume:
121.1K
1-year change:
-57.17%
Market cap:
$18.5M
Revenue:
$15M
EPS (TTM):
-$1.97
Earnings Data
Next earnings date for VVOS
Mar 31
2026
Most recent earnings per share
-$0.49
Beat by $0.02
(Nov 19/2025)
Consensus Estimate
-$0.51
(Nov 19/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VVOS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 | $7.2M | -- | -- | -$0.53 | -- |
| 11/19/2025 | Q3 | $4.7M | $6.8M | -$0.49 | -$0.51 | $0.02 |
| 08/19/2025 | Q2 | $3.4M | $3.8M | -$0.55 | -$0.38 | -$0.17 |
| 05/15/2025 | Q1 | $3.7M | $3M | -$0.45 | -$0.40 | -$0.05 |
| 03/31/2025 | Q4 | $3.9M | $3.7M | -$0.48 | -$0.43 | -$0.05 |
| 11/14/2024 | Q3 | $4.2M | $3.9M | -$0.40 | -$0.70 | $0.30 |
| 08/14/2024 | Q2 | $3.6M | $4.1M | -$0.60 | -$1.05 | $0.45 |
| 05/14/2024 | Q1 | $3.5M | $3.4M | -$1.63 | -$1.16 | -$0.47 |
| 03/28/2024 | Q4 | $3.4M | $3.2M | -$2.32 | -$2.06 | -$0.26 |
| 11/14/2023 | Q3 | $4.5M | $3.3M | -$1.75 | -$3.00 | $1.25 |
| 08/22/2023 | Q2 | -- | $3.4M | -$4.62 | -- | -- |
| 05/16/2023 | Q1 | -- | $3.9M | -$1.72 | -- | -- |
| 03/31/2023 | Q4 | -- | $4M | -$6.62 | -- | -- |
| 11/15/2022 | Q3 | -- | $4.2M | -$6.40 | -- | -- |
| 09/27/2022 | Q2 | -- | $4.2M | -$8.23 | -- | -- |
| 05/16/2022 | Q1 | -- | $3.6M | -$6.28 | -- | -- |
| 03/31/2022 | Q4 | -- | $4.4M | -$8.03 | -- | -- |
| 11/15/2021 | Q3 | -- | $4.5M | -$6.55 | -- | -- |
| 08/12/2021 | Q2 | -- | $4.5M | -$4.87 | -- | -- |
| 05/17/2021 | Q1 | -- | $3.4M | -$4.67 | -- | -- |
| 12/31/2020 | Q4 | -- | $3.3M | -$15.69 | -- | -- |
| 09/30/2020 | Q3 | -- | $3.3M | -$2.84 | -- | -- |
| 06/30/2020 | Q2 | -- | $3.3M | -$2.35 | -- | -- |
| 03/31/2020 | Q1 | -- | $3.2M | -$3.89 | -- | -- |
| 12/31/2019 | Q4 | -- | $3.1M | -$3.95 | -- | -- |
| 09/30/2019 | Q3 | -- | $3.3M | -$4.59 | -- | -- |
Vivos Therapeutics, Inc. Earnings Questions
-
How Much did Vivos Therapeutics, Inc. Generate in Revenue Last Quarter?
Vivos Therapeutics, Inc. reported $6.8M worth of top line sales in its most recent quarter.
-
Did Vivos Therapeutics, Inc. Beat Earnings Last Quarter?
Vivos Therapeutics, Inc. announced earnings per share of -$0.49 which represents a beat of analyst forecast a -$0.51 per share.
-
Is Vivos Therapeutics, Inc. Profitable?
Vivos Therapeutics, Inc. reported $3.6M that represents $0.32 per share over the last quarter.
-
What is the Analyst Consensus for Vivos Therapeutics, Inc. EPS Next Year?
Vivos Therapeutics, Inc.'s earnings are forecast to decrease from -$2.22 per share to -$1.79 per share next year representing a decrease of -3.99%.
-
When is Vivos Therapeutics, Inc.'s Earnings Date?
Vivos Therapeutics, Inc.'s next earnings date is March 31, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
